Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
85.45
+1.33 (1.58%)
At close: Aug 7, 2025, 4:00 PM
85.37
-0.08 (-0.09%)
Pre-market: Aug 8, 2025, 7:26 AM EDT
Endeavor Group Holdings Revenue
Alcon had revenue of $2.47B in the quarter ending March 31, 2025, with 0.57% growth. This brings the company's revenue in the last twelve months to $9.93B, up 3.80% year-over-year. In the year 2024, Alcon had annual revenue of $9.91B with 4.82% growth.
Revenue (ttm)
$9.93B
Revenue Growth
+3.80%
P/S Ratio
4.25
Revenue / Employee
$387,710
Employees
25,599
Market Cap
42.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.91B | 456.00M | 4.82% |
| Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
| Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
| Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
| Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ALC News
- 20 hours ago - STAAR SURGICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of STAAR Surgical Company - STAA - Business Wire
- 2 days ago - Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - GlobeNewsWire
- 3 days ago - Alcon Agrees to Acquire STAAR Surgical - Business Wire
- 4 weeks ago - Alcon's Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Business Wire
- 6 weeks ago - Alcon Canada Earns Global Recognition as a Top Employer - Business Wire
- 6 weeks ago - Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon's Breakthrough Unity Phaco System - GlobeNewsWire
- 6 weeks ago - Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL - Business Wire
- 2 months ago - LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR - Business Wire